Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Jun 1;25(11):2182–2188. doi: 10.1093/nar/25.11.2182

Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.

J Joseph 1, J C Kandala 1, D Veerapanane 1, K T Weber 1, R V Guntaka 1
PMCID: PMC146703  PMID: 9153319

Abstract

The rat alpha1(I) collagen promoter contains a unique polypurine-polypyrimidine sequence between -141 and -200 upstream of the transcription start site. The polypurine sequence from -171 to -200 (C2) is on the coding strand and the adjacent polypurine sequence from -141 to -170 (C1) is on the non-coding strand. Earlier we demonstrated triplex formation with a polypurine 30 nt parallel triplex-forming oligonucleotide (TFO) corresponding to C1 and inhibition of transcriptional activity of the rat alpha1(I) collagen promoter. In the present work we have tested triplex-forming abilities of shorter (18 nt) purine and pyrimidine TFOs in parallel and antiparallel orientation to the C1 purine sequence. Our results show that purine antiparallel TFOs formed triplexes with the highest binding affinities, while pyrimidine oligodeoxyribonucleotides (ODNs) did not show appreciable binding. Phosphorothioate modification of purine TFOs did not significantly reduce binding affinity. We also demonstrate that preformed triplexes are quite stable when precipitated with ethanol and resuspended in water. Further analysis was carried out using two purine phosphorothioate antiparallel TFOs, 158 APS and 164 APS, designed to bind to the promoter region from -141 to -158 and -147 to -164, respectively, which were found to form triplexes even under physiological conditions. DNase I footprinting experiments showed the ability of these TFOs to protect target sequences in the promoter region; both purine sequences (C1 and C2) were protected in the case of 158 APS. Transfection experiments using preformed triplexes with a reporter plasmid containing the collagen promoter sequence showed significant inhibition of transcription when compared with a control phosphorothioate ODN. The effect of 164 APS was greater than that of 158 APS. These results indicate that this triplex strategy could be used in the down-regulation of collagen synthesis in cultured cells and offer the potential to control fibrosis in vivo.

Full Text

The Full Text of this article is available as a PDF (171.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abergel R. P., Chu M. L., Bauer E. A., Uitto J. Regulation of collagen gene expression in cutaneous diseases with dermal fibrosis: evidence for pretranslational control. J Invest Dermatol. 1987 Jun;88(6):727–731. doi: 10.1111/1523-1747.ep12470397. [DOI] [PubMed] [Google Scholar]
  2. Boast S., Su M. W., Ramirez F., Sanchez M., Avvedimento E. V. Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem. 1990 Aug 5;265(22):13351–13356. [PubMed] [Google Scholar]
  3. Brenner D. A., Rippe R. A., Veloz L. Analysis of the collagen alpha 1(I) promoter. Nucleic Acids Res. 1989 Aug 11;17(15):6055–6064. doi: 10.1093/nar/17.15.6055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dagle J. M., Weeks D. L. Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation. Nucleic Acids Res. 1996 Jun 1;24(11):2143–2149. doi: 10.1093/nar/24.11.2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Downer G., Phan S. H., Wiggins R. C. Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest. 1988 Sep;82(3):998–1006. doi: 10.1172/JCI113710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eustice D. C., Feldman P. A., Colberg-Poley A. M., Buckery R. M., Neubauer R. H. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques. 1991 Dec;11(6):739-40, 742-3. [PubMed] [Google Scholar]
  7. Frank-Kamenetskii M. D., Mirkin S. M. Triplex DNA structures. Annu Rev Biochem. 1995;64:65–95. doi: 10.1146/annurev.bi.64.070195.000433. [DOI] [PubMed] [Google Scholar]
  8. Franklin T. J. Current approaches to the therapy of fibrotic diseases. Biochem Pharmacol. 1995 Jan 31;49(3):267–273. doi: 10.1016/0006-2952(94)00354-o. [DOI] [PubMed] [Google Scholar]
  9. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hacia J. G., Wold B. J., Dervan P. B. Phosphorothioate oligonucleotide-directed triple helix formation. Biochemistry. 1994 May 10;33(18):5367–5369. doi: 10.1021/bi00184a002. [DOI] [PubMed] [Google Scholar]
  11. Karsenty G., de Crombrugghe B. Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene. J Biol Chem. 1990 Jun 15;265(17):9934–9942. [PubMed] [Google Scholar]
  12. Kovacs A., Kandala J. C., Weber K. T., Guntaka R. V. Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription. J Biol Chem. 1996 Jan 19;271(3):1805–1812. doi: 10.1074/jbc.271.3.1805. [DOI] [PubMed] [Google Scholar]
  13. Kovacs E. J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991 Jan;12(1):17–23. doi: 10.1016/0167-5699(91)90107-5. [DOI] [PubMed] [Google Scholar]
  14. Latimer L. J., Hampel K., Lee J. S. Synthetic repeating sequence DNAs containing phosphorothioates: nuclease sensitivity and triplex formation. Nucleic Acids Res. 1989 Feb 25;17(4):1549–1561. doi: 10.1093/nar/17.4.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee J. S., Johnson D. A., Morgan A. R. Complexes formed by (pyrimidine)n . (purine)n DNAs on lowering the pH are three-stranded. Nucleic Acids Res. 1979 Jul 11;6(9):3073–3091. doi: 10.1093/nar/6.9.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Maher L. J., 3rd, Dervan P. B., Wold B. Analysis of promoter-specific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system. Biochemistry. 1992 Jan 14;31(1):70–81. doi: 10.1021/bi00116a012. [DOI] [PubMed] [Google Scholar]
  17. McShan W. M., Rossen R. D., Laughter A. H., Trial J., Kessler D. J., Zendegui J. G., Hogan M. E., Orson F. M. Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem. 1992 Mar 15;267(8):5712–5721. [PubMed] [Google Scholar]
  18. Morgan A. R., Wells R. D. Specificity of the three-stranded complex formation between double-stranded DNA and single-stranded RNA containing repeating nucleotide sequences. J Mol Biol. 1968 Oct 14;37(1):63–80. doi: 10.1016/0022-2836(68)90073-9. [DOI] [PubMed] [Google Scholar]
  19. Musso M., Van Dyke M. W. Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides. Nucleic Acids Res. 1995 Jun 25;23(12):2320–2327. doi: 10.1093/nar/23.12.2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Olivas W. M., Maher L. J., 3rd Competitive triplex/quadruplex equilibria involving guanine-rich oligonucleotides. Biochemistry. 1995 Jan 10;34(1):278–284. doi: 10.1021/bi00001a034. [DOI] [PubMed] [Google Scholar]
  21. Orson F. M., Thomas D. W., McShan W. M., Kessler D. J., Hogan M. E. Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res. 1991 Jun 25;19(12):3435–3441. doi: 10.1093/nar/19.12.3435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Postel E. H., Flint S. J., Kessler D. J., Hogan M. E. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8227–8231. doi: 10.1073/pnas.88.18.8227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rougée M., Faucon B., Mergny J. L., Barcelo F., Giovannangeli C., Garestier T., Hélène C. Kinetics and thermodynamics of triple-helix formation: effects of ionic strength and mismatches. Biochemistry. 1992 Sep 29;31(38):9269–9278. doi: 10.1021/bi00153a021. [DOI] [PubMed] [Google Scholar]
  24. Sarhan S., Seiler N. On the subcellular localization of the polyamines. Biol Chem Hoppe Seyler. 1989 Dec;370(12):1279–1284. doi: 10.1515/bchm3.1989.370.2.1279. [DOI] [PubMed] [Google Scholar]
  25. Singleton S. F., Dervan P. B. Equilibrium association constants for oligonucleotide-directed triple helix formation at single DNA sites: linkage to cation valence and concentration. Biochemistry. 1993 Dec 7;32(48):13171–13179. doi: 10.1021/bi00211a028. [DOI] [PubMed] [Google Scholar]
  26. Stein C. A., Cheng Y. C. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science. 1993 Aug 20;261(5124):1004–1012. doi: 10.1126/science.8351515. [DOI] [PubMed] [Google Scholar]
  27. Svinarchuk F., Bertrand J. R., Malvy C. A short purine oligonucleotide forms a highly stable triple helix with the promoter of the murine c-pim-1 proto-oncogene. Nucleic Acids Res. 1994 Sep 11;22(18):3742–3747. doi: 10.1093/nar/22.18.3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Washbrook E., Fox K. R. Alternate-strand DNA triple-helix formation using short acridine-linked oligonucleotides. Biochem J. 1994 Jul 15;301(Pt 2):569–575. doi: 10.1042/bj3010569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weber K. T., Brilla C. G., Janicki J. S. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993 Mar;27(3):341–348. doi: 10.1093/cvr/27.3.341. [DOI] [PubMed] [Google Scholar]
  30. Weber K. T., Janicki J. S., Shroff S. G., Pick R., Chen R. M., Bashey R. I. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988 Apr;62(4):757–765. doi: 10.1161/01.res.62.4.757. [DOI] [PubMed] [Google Scholar]
  31. de Bizemont T., Duval-Valentin G., Sun J. S., Bisagni E., Garestier T., Hélène C. Alternate strand recognition of double-helical DNA by (T,G)-containing oligonucleotides in the presence of a triple helix-specific ligand. Nucleic Acids Res. 1996 Mar 15;24(6):1136–1143. doi: 10.1093/nar/24.6.1136. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES